Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis-Reference-Cited by-同舟云学术

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Published:2012-11 Issue:18 Volume:367 Page:1714-1723
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Boonen Steven,Reginster Jean-Yves,Kaufman Jean-Marc,Lippuner Kurt,Zanchetta Jose,Langdahl Bente,Rizzoli Rene,Lipschitz Stanley,Dimai Hans Peter,Witvrouw Richard,Eriksen Erik,Brixen Kim,Russo Luis,Claessens Frank,Papanastasiou Philemon,Antunez Oscar,Su Guoqin,Bucci-Rechtweg Christina,Hruska Josef,Incera Elodie,Vanderschueren Dirk,Orwoll Eric

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1204061

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study;BMC Musculoskeletal Disorders;2024-09-02

2. Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials;Clinical Orthopaedics & Related Research;2024-08-22

3. Approaches to diagnosis and treatment of osteoporosis and prevention of recurrent fractures in men in therapeutic practice: Clinical cases;Meditsinskiy sovet = Medical Council;2024-08-15

4. The Case for Bisphosphonate Use in Astronauts Flying Long-Duration Missions;Cells;2024-08-13

5. Osteoporosis treatment: current drugs and future developments;Frontiers in Pharmacology;2024-08-12